In 1982, recombinant human insulin became the first biotech therapy to earn FDA approval. The product was developed by Genentech and Eli Lilly and Co.
Media Inquiry
- For Students
- For Teachers
- Programs
- International BioGENEius Challenge
- Testimonials
- Volunteer Opportunities
- U.S. National BioGENEius Challenge
- Local BioGENEius Challenges
- Local Partner Contact Information
- Bay Area BioGENEius Challenge
- Delaware BioGENEius Challenge
- Florida BioGENEius Challenge
- Georgia BioGENEius Challenge
- Kansas BioGENEius Challenge
- Massachusetts BioGENEius Challenge
- New Mexico BioGENEius Challenge
- Pennsylvania BioGENEius Challenge
- Southern California (SoCal) BioGENEius Challenge
- Texas BioGENEius Challenge
- Virginia BioGENEius Challenge
- Application Deadlines and Events
- Judging Criteria (Local)
- "Roll up" Poster Instructions
- Local Partner Contact Information
- At-Large BioGENEius Challenge Competition
- About the Institute
- Supporters
- What is Biotechnology?
